Evidence map›Paper›PMID 9863598›Full record

ArticleJournal of medical genetics1998

The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy.

R de Franchis, A Buoninconti, C Mandato, A Pepe, M P Sperandeo, R Del Gado, V Capra, E Salvaggio, G Andria, P Mastroiacovo

Abstract read
In one paragraph

Article in Journal of medical genetics, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Neural tube defects, folic acid and methylation.International journal of environmental research and public health · 2013
    Review
  7. Osteoporosis in paediatric patients with spina bifida.The journal of spinal cord medicine · 2012
    Review
  8. Article
  9. Homocysteine, folate, lipid profile and MTHFR genotype and disability in children with myelomeningocele.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2006
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

R de FranchisDepartment of Paediatrics, Federico II University, Napoli, Italy.
A Buoninconti
C Mandato
A Pepe
M P Sperandeo
R Del Gado
V Capra
E Salvaggio
G Andria
P Mastroiacovo

Funding

Telethon E.0439
6 · The paper itself

Abstract

objectiveTo estimate the risk for spina bifida associated with the common mutation C677T of the MTHFR gene in a country with a relatively low prevalence of NTDs.

designCase-control study. SUBJECTS: CASES: 203 living patients affected with spina bifida (173 myelomeningocele and 30 lipomeningocele); controls: 583 subjects (306 young adults and 277 unselected newborns) from northern and central-southern Italy.

settingCASES: three spina bifida centres; young adult controls: DNA banks; newborn controls: regional neonatal screening centres.

main outcome measuresPrevalence of the C677T genotypes in cases and controls by place of birth; odds ratios for spina bifida and estimated attributable fraction.

resultsThe prevalence of T/T, T/C, and C/C genotype was 16.6%, 53.7%, and 29.7% in controls and 25.6%, 43.8%, and 30.6% in cases, respectively. We found no differences between type of defect or place of birth. The odds ratio for spina bifida associated with the T/T genotype v C/C plus T/C was 1.73 (95% CI 1.15, 2.59) and the corresponding attributable fraction was 10.8%. No increased risk was found for heterozygous patients (OR=0.79, 95% CI 0.53-1.18).

conclusionThis study, as well as the meta-analysis we updated, shows that homozygosity for the MTHFR C677T mutation is a moderate risk factor in Europe, and even in Italy where there is a relatively low prevalence of spina bifida. The estimated attributable fraction associated with this risk factor explains only a small proportion of cases preventable by periconceptional folic acid supplementation. Thus, other genes involved in folate-homocysteine metabolism, their interaction, and the interaction between genetic and environmental factors should be investigated further.

Indexed as

Point Mutation5,10-Methylenetetrahydrofolate Reductase (FADH2)AdultCase-Control StudiesChildCysteineGenotypeHumansInfant, NewbornItalyMeta-Analysis as TopicMethylenetetrahydrofolate Dehydrogenase (NAD+)Methylenetetrahydrofolate Dehydrogenase (NADP)Methylenetetrahydrofolate Reductase (NADPH2)Middle AgedOxidoreductases5,10-Methylenetetrahydrofolate Reductase (FADH2)CysteineMethylenetetrahydrofolate Dehydrogenase (NAD+)Methylenetetrahydrofolate Dehydrogenase (NADP)Methylenetetrahydrofolate Reductase (NADPH2)OxidoreductasesOxidoreductases Acting on CH-NH Group DonorsThreonine

Identifiers

PMID9863598
PMCPMC1051513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.